988
Participants
Start Date
July 9, 2024
Primary Completion Date
June 30, 2028
Study Completion Date
December 31, 2028
Fibrogammin
Fibrogammin is administered according to the Summary of product characteristics (SmPC) after measured blood loss exceeds 700 ml and bleeding is ongoing
RECRUITING
University Hospital Lausanne, Lausanne
NOT_YET_RECRUITING
University Hospital Geneva, Geneva
RECRUITING
Inselspital-University Hospital Bern, Bern
RECRUITING
University Hospital Basel, Basel
RECRUITING
Cantonal Hospital Baden, Baden
RECRUITING
University Hospital of Zurich, Zurich
RECRUITING
Spital Zollikerberg, Zollikerberg
RECRUITING
Cantonal Hospital Winterthur, Winterthur
RECRUITING
Cantonal Hospital St. Gallen, Sankt Gallen
Swiss National Science Foundation, Switzerland
UNKNOWN
Christian Haslinger
OTHER